Reactions 1704, p329 - 2 Jun 2018 Hypotension and falls: case report A 70-year-old man developed hypotension and fall while receiving treatment with quetiapine for acute psychosis [route, dosage, duration of treatment to reaction onset and outcome not stated]. The man, who had Parkinson’s disease, presented to emergency department for worsening delusions, agitation and hallucinations. He was admitted to the psychiatric ward for acute psychosis. Prior to the presentation, he was receiving treatment with levodopa-carbidopa, which was discontinued after the presentation. However, no improvement was noted in his condition. He required increasing doses of quetiapine, but the therapy resulted in the developed of hypotension and falls. The man’s quetiapine therapy was changed to pimavanserin. About 3 4 months after the initial presentation to the emergency department, and despite receiving treatment with various medications, he was unable to walk, had bladder and bowel incontinence, and was disoriented to time and place. Author comment: "He required increasing doses of quetiapine which caused hypotension and falls." Kamalfar S. Home or heaven: Which way am I headed?. Journal of the American Geriatrics Society 66 (Suppl. 2): S187-S188 abstr. C44, Apr 2018. Available from: URL: https://doi.org/10.1111/jgs.15376 [abstract] - USA 803323451 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera